Status:
UNKNOWN
Necessity of Aspiration in the Ventrogluteal Site
Lead Sponsor:
Ege University
Conditions:
Nursing
Injection Site
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
H1: Aspiration is not necessary for IM injections applied from the ventrogluteal region. H2: Aspiration procedure increases pain in IM injections applied from ventrogluteal region. H3: The duration ...
Eligibility Criteria
Inclusion
- Patient who came to the Emergency Service Care Unit for "Diclofenac Sodium" injection
- Have no vision and hearing problems,
- Who have no disease that may affect their perception of pain
- Who can evaluate the "Visual Analog Scale" correctly, scoring 5 points or less from the VAS,
- Body Mass Index is between 18.5-24.9 kg / m2,
- Who do not have any discomfort in the extremities that will prevent them from taking the desired position,
- No complications due to intramuscular injections such as abscess, infection, tissue necrosis and hematoma in the ventrogluteal region
- No nodules or masses in the area
Exclusion
- Patients who refuse the injection are excluded.
Key Trial Info
Start Date :
January 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2020
Estimated Enrollment :
834 Patients enrolled
Trial Details
Trial ID
NCT04421599
Start Date
January 14 2019
End Date
June 20 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University Hospital
Izmir, Turkey (Türkiye)